Chemical Compound

[1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2); [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-, compd. with 2-aminoethanol (1:2) (9CI); Eltrombopag diethanolamine salt; Eltrombopag olamine; Promacta; Revolade; SB 497115GR; SB-497115GR; SB497115GR Test Mix 1; SB497115GR

CAS Registry Number 496775-62-3
[1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2); [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-, compd. with 2-aminoethanol (1:2) (9CI); Eltrombopag diethanolamine salt; Eltrombopag olamine; Promacta; Revolade; SB 497115GR; SB-497115GR; SB497115GR Test Mix 1; SB497115GR 结构式
Primary record

[1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2); [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-, compd. with 2-aminoethanol (1:2) (9CI); Eltrombopag diethanolamine salt; Eltrombopag olamine; Promacta; Revolade; SB 497115GR; SB-497115GR; SB497115GR Test Mix 1; SB497115GR

库存
5,845 克
纯度
98.4 %
CAS
496775-62-3

化合物标识与属性

CAS
496775-62-3
PubChem CID
135449331
SMILES
CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N
Canonical SMILES
Cc1ccc(-n2[nH]c(C)c(N=Nc3cccc(-c4cccc(C(=O)O)c4)c3O)c2=O)cc1C.NCCO.NCCO

名称与同义词

  • Eltrombopag olamine
  • Promacta
  • Revolade
  • 496775-62-3
  • Eltrombopag (Olamine)
  • 2-aminoethanol
  • UNII-4U07F515LG
  • Eltrombopagolamine
  • Promacta (TN)
  • Eltrombopag olamine?
  • Eltrombopag (as olamine)
  • EltroMbopag diethanolaMine salt
  • SB-497115-GR
  • 496775-62-3 (olamine)
  • Eltrombopag olamine [USAN:JAN]
  • Eltrombopag Olamine [USAN]
  • SCHEMBL210183
  • MFCD22380664
  • 4U07F515LG
  • AMY267
  • orb1300431
  • CHEMBL3989691
  • SCHEMBL16207741
  • SCHEMBL23458316
  • SCHEMBL29386642
  • SCHEMBL29452757
  • Eltrombopag olamine (JAN/USAN)
  • SB 497115GR
  • ELTROMBOPAG OLAMINE [JAN]
  • CHEBI:234330
  • Eltrombopag (Olamine) (Standard)
  • PLILLUUXAVKBPY-SBIAVEDLSA-N
  • C29H36N6O6
  • ELTROMBOPAG OLAMINE [USAN]
  • GLXC-06920
  • HMS5080A20
  • HY-15306AR
  • BCP07055
  • C25H22N4O4.2C2H7NO
  • Eltrombopag (SB497115) Olamine
  • ELTROMBOPAG OLAMINE [MART.]
  • SB-497115GR
  • 3608AH
  • ELTROMBOPAG OLAMINE [WHO-DD]
  • HY-15306A
  • MFCD30181471
  • s2229
  • AKOS025396658
  • AKOS037515856
  • CCG-270074
  • CID9915926
  • CS-1566
  • SB19102
  • CID 9915926
  • ELTROMBOPAG OLAMINE [ORANGE BOOK]
  • AC-26286
  • BS-17370
  • Eltrombopag compd with 2-aminoethanol (1:2)
  • Eltrombopag diethanolamine salt;SB-497115GR
  • FD157443
  • PD087725
  • SY046957
  • SB-497115
  • A3387
  • FT-0773802
  • A15078
  • D03978
  • Z-3296
  • C25-H22-N4-O4.2(C2-H7-N-O)
  • Q27260489
  • ELTROMBOPAG COMPD WITH 2-AMINOETHANOL (1:2) [MI]
  • (Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxyiic acid;2-aminoethan-1-ol (1:2)
  • 2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid
  • 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
  • (1,1'-Biphenyl)-3-carboxylic acid, 3'-((2Z)-(1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene)hydrazino)-2'-hydroxy, compound with 2-Aminoethanol (1:2)
  • (Z)-3 inverted exclamation mark -[2-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxopyrazol-4(5H)-ylidene]hydrazino]-2 inverted exclamation mark -hydroxybiphenyl-3-carboxylic Acid compd. with 2-Aminoethanol (1:2)
  • [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-, compd. with 2-aminoethanol (1:2)
  • [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2)
  • [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2); [1,1'-Biphenyl]-3-carboxylic acid, 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-, compd. with 2-aminoethanol (1:2) (9CI); Eltrombopag diethanolamine salt; Eltrombopag olamine; Promacta; Revolade; SB 497115GR; SB-497115GR; SB497115GR Test Mix 1; SB497115GR
  • [1,1'-Biphenyl]-3-carboxylic acid, 3'-[2-[1-(3,4-dimethylphenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl]diazenyl]-2'-hydroxy-, compd. with 2-aminoethanol (1:2)
  • 2-aminoethan-1-ol hemi((E)-3'-(2-(2-(3,4-dimethylphenyl)-5-methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl)hydrazono)-2'-oxo-2',3'-dihydro-[1,1'-biphenyl]-3-carboxylate)
  • 2-aminoethan-1-ol hemi((Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazineyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate)
  • 2-Aminoethan-1-ol hemi((Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate)
  • 2-Aminoethanol (E)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate
  • 2-aminoethanol;3-[(5E)-5-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]hydrazinylidene]-6-oxocyclohexa-1,3-dien-1-yl]benzoic acid
  • 2-aminoethanol;3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]azo]-2-hydroxy-phenyl]benzoic acid
  • 3'-((2Z)-2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)diazanyl)-2'-hydroxybiphenyl-3-carboxylic acid compound with 2-aminoethanol (1:2)
  • 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
  • 3'-[(2Z)-2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]diazanyl]-2'-hydroxybiphenyl-3-carboxylic acid compound with 2-aminoethanol (1:2)
  • 3-[(5E)-5-{2-[1-(3,4-DIMETHYLPHENYL)-3-METHYL-5-OXO-2H-PYRAZOL-4-YL]HYDRAZIN-1-YLIDENE}-6-OXOCYCLOHEXA-1,3-DIEN-1-YL]BENZOIC ACID; BIS(ETHANOLAMINE)
  • 3-[3-[[2-(3,4-dimethylphenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid